Globus Medical CEO Daniel Scavilla has resigned to take over the corner office at Dentsply Sirona, the companies announced ...

Globus Medical Inc. (NYSE: GMED) is one of the most undervalued stocks to buy and hold for 3 years. On July 22, Canaccord ...

Globus Medical Inc. (NYSE:GMED) is one of the best mid cap pharma stocks to buy. On July 15, Globus Medical announced the ...

Dan Scavilla stepped down as president and CEO of Globus Medical, and Keith Pfeil succeeded him, the company said July 21. Mr. Scavilla resigned to pursue a new opportunity effective July 18, ...

Globus Medical (GMED) on Monday appointed Keith Pfeil as President and Chief Executive Officer, effective July 18, 2025. Pfeil, who is currently the Executive V ...

Throughout the last three months, 4 analysts have evaluated Globus Medical GMED, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and ...

LEM Surgical, a robotics company for spine and hard tissue surgery, added leaders from Globus Medical and Medtronic to its team. Dave Demski, who was CEO at Globus Medical, joined LEM Surgical’s board ...

All You Need to Know About Globus Medical Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers.

Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term dilution. Read the full GMED stock analysis.

Globus Medical expands its Power Portfolio with the DuraPro™ oscillating system, enhancing surgical navigation and efficiency.

A medical professional conducting a minimally invasive procedure using a cutting-edge medical device. Globus Medical, Inc. (NYSE:GMED) is not on our list of 30 Most Popular Stocks Among Hedge Funds.